Laboratory diagnosis of Clostridium difficile infection: Can molecular amplification methods move us out of uncertainty?

Journal of Molecular Diagnostics

Volumn 13, Issue 6, 2011, Pages 573-582

  Tenover, Fred C ^a   Baron, Ellen Jo ^a   Peterson, Lance R ^b   Persing, David H ^a  

^a CEPHEID   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CYTOTOXIN; GLUTAMATE DEHYDROGENASE;

ALGORITHM; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL CULTURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COST; ENZYME IMMUNOASSAY; FECES ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 82955220507     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2011.06.001     Document Type: Review

References (64)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455
2. Eastwood K, Else P, Charlett A, Wilcox M: Comparison of nine commercially available Clostridium difficile toxin detection assays, a realtime PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217
3. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ: European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009, 15:1053-1066
4. Schmidt ML, Gilligan PH: Clostridium difficile testing algorithms: what is practical and feasible? Anaerobe 2009, 15:270-273
5. Peterson LR, Robicsek A: Does my patient have Clostridium difficile infection? Ann Intern Med 2009, 151:176-179
6. Wilcox MH, Planche T, Fang FC, Gilligan P: Point-counterpoint: what is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010, 48:4347-4353
7. Gilligan PH: Is a two-step glutamate dehydrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J Clin Microbiol 2008, 46:1523-1525
8. Swindells J, Brenwald N, Reading N, Oppenheim B: Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010, 48:606-608
9. Doing KM, Hintz MS, Keefe C, Horne S, LeVasseur S, Kulikowski ML: Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures. Diagn Microbiol Infect Dis 2010, 66:129-134
10. Quinn CD, Sefers SE, Babiker W, He Y, Alcabasa R, Stratton CW, Carroll KC, Tang YW: C. Diff Quik Chek Complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 2010, 48:603-605
11. Hall IC, O'Toole E: Intestinal flora in new-born infants with a description of a new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child 1935, 49:390-402
12. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978, 298:531-534 (Pubitemid 8295586)
13. Lyerly DM, Krivan HC, Wilkins TD: Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988, 1:1-18
14. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW: Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996, 100:32-40 (Pubitemid 26049323)
15. Rupnik M, Dupuy B, Fairweather NF, Gerding DN, Johnson S, Just I, Lyerly DM, Popoff MR, Rood JI, Sonenshein AL, Thelestam M, Wren BW, Wilkins TD, von Eichel-Streiber C: Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 2005, 54:113-117 (Pubitemid 40867994)
16. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI: Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458:1176-1179
17. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP: The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467:711-713
18. Leav BA, Blair B, Leney M, Knauber M, Reilly C, Lowy I, Gerding DN, Kelly CP, Katchar K, Baxter R, Ambrosino D, Molrine D: Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine 2010, 28:965-969
19. Rupnik M: Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 2008, 32:541-555
20. Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, Burstin H, Calfee DP, Coffin SE, Fraser V, Griffin FA, Gross P, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS: Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S81-S92
21. Akerlund T, Persson I, Unemo M, Norén T, Svenungsson B, Wullt M, Burman LG: Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 2008, 46:1530-1533 (Pubitemid 351563610)
22. McFarland LV: What's lurking under the bed? persistence and predominance of particular Clostridium difficile strains in a hospital and the potential role of environmental contamination. Infect Control Hosp Epidemiol 2002, 23:639-640
23. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, Lyras D, Rood JI, DeGirolami P, Baltch AL, Rafferty ME, Pear SM, Gerding DN: Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999, 341:1645-1651
24. Kuijper EJ, Coignard B, Tull P: Emergence of Clostridium difficileassociated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl 6):2-18 (Pubitemid 44362038)
25. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441 (Pubitemid 41770164)
26. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, Carroll KC: Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009, 47:373-378
27. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C: Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009, 47:1276-1277
28. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE: Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008, 46:1996-2001 (Pubitemid 351831833)
29. Musher DM, Manhas A, Jain P, Nuila F, Waqar A, Logan N, Marino B, Graviss EA: Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol 2007, 45:2737-2739 (Pubitemid 47295519)
30. van den Berg RJ, Vaessen N, Endtz HP, Schulin T, van der Vorm ER, Kuijper EJ: Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol 2007, 56:36-42 (Pubitemid 46036272)
31. Reyes RC, John MA, Ayotte DL, Covacich A, Milburn S, Hussain Z: Performance of TechLab C. DIFF QUIK CHEK and TechLab C: DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn Microbiol Infect Dis 2007, 59:33-37 (Pubitemid 47391180)
32. Peterson LR, Olson MM, Shanholtzer CJ, Gerding DN: Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis 1988, 10:85-91
33. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH: Impact of strain types on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010, 48: 3719-3724
34. Novak-Weekley SM, Marlowe EM, Miller JM, Cumpio J, Nomura JH, Vance PH, Weissfeld A: Clostridium difficile testing in the clinical laboratory using multiple testing algorithms. J Clin Microbiol 2010, 48:889-893
35. Stamper PD, Babiker W, Alcabasa R, Aird D, Wehrlin J, Ikpeama I, Gluck L, Carroll KC: Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J Clin Microbiol 2009, 47:3846-3850
36. Norén T, Alriksson I, Andersson J, Akerlund T, Unemo M: Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard. J Clin Microbiol 2011, 49:710-711
37. Lalande V, Barrault L, Wadel S, Eckert C, Petit JC, Barbut F: Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 2011, 49:2714-2716
38. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY: National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009, 37:263-270
39. Koransky Jr, Allen SD, Dowell VR Jr: Use of ethanol for selective isolation of sporeforming microorganisms. Appl Environ Microbiol 1978, 35:762-765 (Pubitemid 8316429)
40. George WL, Sutter VL, Citron D, Finegold SM: Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979, 9:214-219 (Pubitemid 9123787)
41. Wilson KH, Kennedy MJ, Fekety FR: Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol 1982, 15:443-446 (Pubitemid 12178880)
42. Johnson EA, Summanen P, Finegold SM: Clostridium. In: Manual of Clinical Microbiology, 9th Edition. Edited by PR Murray, EJ Baron, JH Jorgensen, ML Landry, MA Pfaller. Washington, ASM Press, 2007, pp 889-910
43. Freeman J, Wilcox M: The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol 2003, 56:126-128 (Pubitemid 36177255)
44. Alcala L, Sanchez-Cambronero L, Catalan MP, Sanchez-Somolinos M, Pelaez MT, Marin M, Bouza E: Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol 2008, 46:3833-3835
45. Shetty N, Wren MW, Coen PG: The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a metaanalysis. J Hosp Infect 2011, 77:1-6
46. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, Carroll KC: Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007, 45:3601-3605 (Pubitemid 350156855)
47. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC: Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006, 44:1145-1149
48. Larson AM, Fung AM, Fang FC: Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol 2010, 48:124-130
49. Kurtz CB, Cannon EP, Brezzani A, Pitruzzello M, Dinardo C, Rinard E, Acheson DW, Fitzpatrick R, Kelly P, Shackett K, Papoulis AT, Goddard PJ, Barker RH Jr, Palace GP, Klinger JD: GT160-246, a toxinbinding polymer for treatment of Clostridium difficile colitis. Antimicrob Agents Chemother 2001, 45:2340-2347 (Pubitemid 32664476)
50. Guo J-H, Skinner GW, Harcum WW, Barnum PE: Pharmaceutical applications of naturally occurring water soluble polymers. Pharm Sci Technol Today 1998, 1:254-261 (Pubitemid 28439297)
51. Jensen GL, Bross JE, Bourbeau PP, Naumovitz DW, Streater M, Gianferante LE: Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. J Infect Dis 1994, 170:227-230 (Pubitemid 24186452)
52. Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990, 276: 172-174
53. Karre T, Sloan L, Patel R, Mandrekar J, Rosenblatt J: Comparison of two commercial molecular assays to a laboratory developed molecular assay for diagnosis of Clostridium difficile infection. J Clin Microbiol 2011, 49:725-727
54. Kvach EJ, Ferguson D, Riska PF, Landry ML: Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2009, 48:109-114
55. Gumerlock PH, Tang YJ, Weiss JB, Silva J Jr: Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol 1993, 31:507-511 (Pubitemid 23059857)
56. Huang H, Weintraub A, Fang H, Nord CE: Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 2009, 47:3729-3731
57. Babady NE, Stile J, Ruggiero P, Khosa P, Huang D, Shuptar S, Kamboj M, Kiehn TE: Evaluation of the Cepheid Xpert Clostridium difficile epi assay for diagnosis C. difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010, 48:4519-4524
58. Kato H, Yokoyama T, Arakawa Y: Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification. J Clin Microbiol 2005, 43:6108-6112 (Pubitemid 43100667)
59. Couturier B, She RC: The Illumigene C. difficile Assay Detects Both A+B+ and A-B+ Toxin-Producing Strains of Clostridium difficile. (Abstract ID55, 16th Annual Meeting of the Association for Molecular Pathology). Edited by the Association for Molecular Pathology, Bethesda, MD. 2010, p 34
60. Clinical and Laboratory Standards Institute: Molecular Diagnostic Methods for Infectious Diseases, MM3-A2 Approved Guideline, ed 2. Edited by the Clinical and Laboratory Standards Institute, Wayne, PA, 2006, p 25
61. Luo RF, Banaei N: Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010, 48:3738-3741
62. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM: Evaluation of the C. Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 2010, 48:2082-2086
63. Lee TL, Hacek DM, Stroupe KT, Collins SM, Peterson LR: Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect Control Hosp Epidemiol 2005, 26:39-46 (Pubitemid 40110967)
64. Peterson LR, Hacek DM, Robicsek A: 5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Saf 2007, 33:732-738